Pérez Named Ultimate CEO by South Florida Business Journal
South Florida Business Journal named Jorge Pérez, ’72, founder and Chief Executive Officer of Related Group, to its prestigious list of Ultimate CEO’s for...
Pharmaceutical Specialist Joins International Drug Developer
Ami Patel ’05, ’16 was selected as the senior director of product development for Boyds, a global pharmaceutical consultancy service supporting the development of...
LIU Votes! Initiative Encourages Civic Engagement
Long Island University Athletics launched the LIU Votes! initiative at the beginning of October. The goal of the program was to get 100% of...
Blake Named Director at Greystone
Christopher Blake (MBA, ’99) is the new Director at Greystone & Co., a leading national commercial real estate lending, investment, and advisory company. Blake boasts more...
Abt Associates’ New Chief Operations Officer
Lisa Simeon, ’97, was appointed Chief Operations Officer at Abt Associates, a global consulting and research firm. Simeon previously served as Chief Human Resources...
Nassau County Celebrates 125 Years at Sharks Home Opener
In celebration of its 125th anniversary, Nassau County hosted “Nassau Day” at Bethpage Federal Credit Union Stadium during the Sharks' home opener against Lehigh....
Expanding Financial Tech Company Adds New Vice President
Michael Baez ’88, ’91 was selected as the vice president of professional services and customer strategy for Leasepath, a cloud-based intelligent workplace finance organization...
Executive Director Appointed to Lead BOCES HR Operations
Thomas McGrath ’93 was selected as the executive director of the department of human resources for Nassau BOCES. McGrath previously served as an administrator...
Life-Saving Stroke Therapy Earns NIH’s Top Score
In partnership with biotech start-up Aneuryst, Long Island University is developing fasudil, a Rho-kinase inhibitor with the potential to redefine care for subarachnoid hemorrhage...
Weinand Named Chairman at Replimune Group
Dieter Weinand (MS ’87) was appointed Chairman of the Board of Directors at Replimune Group Inc. (REPL), a biotechnology company developing oncolytic immuno-gene therapies....